Matches in SCALES for { <http://schemas.scales-okn.org/rdf/scales#/DocketEntry/ilnd;;1:08-cv-01083_de640> ?p ?o ?g. }
Showing items 1 to 5 of
5
with 100 items per page.
- ilnd;;1:08-cv-01083_de640 RegisterActionDate "2011-03-30" @default.
- ilnd;;1:08-cv-01083_de640 RegisterActionDescriptionText "WRITTEN Opinion entered by the Honorable Robert M. Dow, Jr on 3/30/2011: Before the Court are Defendants Pentech Pharmaceuticals, Inc. and Cobrek Pharmaceuticals, Inc.s (collectively, Defendants) motion for summary judgment 473 of invalidity of claim 7 of U.S. Patent No. 5,602,116 (the 116 patent) for lack of enablement and lack of written description, and Plaintiffs Bone Care International, LLC and Genzyme Corporations (collectively, Plaintiffs) cross-motion for summary judgment 492 that the 116 paten is enabled as of the filing date of its parent patent application. For the reasons below, the Court denies both motions [473, 492]. Notices Mailed by Judge's Staff (tbk, ) (Entered: 03/30/2011)" @default.
- ilnd;;1:08-cv-01083_de640 AdministrativeID "643" @default.
- ilnd;;1:08-cv-01083_de640 hasReferenceToOtherEntry ilnd;;1:08-cv-01083_de471 @default.
- ilnd;;1:08-cv-01083_de640 hasReferenceToOtherEntry ilnd;;1:08-cv-01083_de490 @default.